Atomic description of the immune complex involved in heparin-induced thrombocytopenia-Reference-Cited by-同舟云学术

Atomic description of the immune complex involved in heparin-induced thrombocytopenia

Published:2015-09-22 Issue:1 Volume:6 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Cai Zheng,Yarovoi Serge V.,Zhu Zhiqiang,Rauova Lubica,Hayes Vincent,Lebedeva Tatiana,Liu Qun,Poncz Mortimer,Arepally Gowthami,Cines Douglas B.,Greene Mark I.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms9277.pdf

Reference54 articles.

1. Linkins, L. A. et al. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141, e495S–e4530 (2012).

2. Phillips, K. W., Dobesh, P. P. & Haines, S. T. Considerations in using anticoagulant therapy in special patient populations. Am. J. Health Syst. Pharm. 65, S13–S21 (2008).

3. Lee, G. M. & Arepally, G. M. Heparin-induced thrombocytopenia. Hematology Am. Soc. Hematol. Educ. Program 2013, 668–674 (2013).

4. Lewis, B. E. et al. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia. Arch. Intern. Med. 163, 1849–1856 (2003).

5. Cuker, A. & Cines, D. B. How I treat heparin-induced thrombocytopenia. Blood 119, 2209–2218 (2012).

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemokine Oligomers and the Impact of Fondaparinux Binding;Journal of the American Society for Mass Spectrometry;2024-06-05

2. Evaluating Diagnostic Algorithms for Heparin-Induced Thrombocytopenia using Two Combined Automated Rapid Immunoassays;Seminars in Thrombosis and Hemostasis;2024-05-11

3. Molecular architecture and platelet-activating properties of small immune complexes assembled on heparin and platelet factor 4;Communications Biology;2024-03-11

4. Characterization of reverse-engineered anti-PF4 stereotypic antibodies derived from serum of patients with VITT;Blood;2024-01-25

5. Transient Autoreactive PF4 and Antiphospholipid Antibodies in COVID-19 Vaccine Recipients;Vaccines;2023-12-14